Aktivität und Vorkommen geflügelter Blattläuse auf Freilandpaprika in Spanien

Horizontal mosaic-green-tile traps were placed in various pepper-growing areas of Spain: Aranjuez and Arganda del Rey (Madrid), Balboa (Badajoz), Cadreita (Pamplona), Mendavia and Sartaguda (Logroño), Montañana (Zaragoza), Pueblo Nuevo (Valencia) and Torrepacheco (Murcia). These mosaic-greentraps resembled much better the pepper canopy than the commonly used yellow water traps, as indicated by absorbance spectrophotometry. Sampling was extended throughout the pepper crop cycle during 1990, 1991 and 1992. Over that time, 14,363 aphids, belonging to 99 species/taxa were captured. Aphis was the principal genus captured: 57.5 % of the total (17 % belonging to the species Aphis fabae (Scopoli)). Other abundant species were: Myzus (Nectarosiphon) persicae (Sulzer) (7.46 %), Diuraphis noxia (Mordvilko) (5.23 %), Brachycaudus spp. (3.73 %), Sitobion avenae (F.) (2.51 %), Macrosiphum euphorbiae (Thomas) (2.46 %), Rhopalosiphum spp. (2.20 %) and Therioaphis spp. (1.99 %). The species included in the genus Aphis were the most abundant in all the regions sampled, although M. (N.) persicae was also predominant in the Zaragoza and Pamplona region, and D. noxia was frequently found in the Madrid region. A first aphid peak was observed soon after transplanting (May–June) in most of the regions and years sampled.Horizontale mosaikgrüne Farbfallen wurden in verschiedenen Paprika-Anbaugebieten in Spanien aufgestellt: Aranjuez und Arganda del Rey (Madrid), Balbao (Badajoz), Cadreita (Pamplona), Mendavia und Sartaguda (Logroño), Montañana (Zaragoza), Pueblo Nuevo (Valencia) und Torrepacheco (Murcia). Diese mosaikgrünen Fallen ähnelten sehr viel besser den Farben des Paprikabestandes als die üblicherweise eingesetzten gelben Wasserfallen wie durch Absorptionsspektrometrie festgestellt wurde. Die Probennahmen erfolgten während der ganzen Wachstumsphasen des Paprikas in den Jahren 1990, 1991 und 1992. In diesen Zeiträumen konnten 14363 Blattläuse gefangen werden, die 99 Arten/Taxa angehörten. Die Gattung Aphis wurde mit 57,5 % am häufigsten gefangen, 17 % gehörten zur Art Aphis fabae (Scopoli). Andere häufig vorkommende Arten waren: Myzus (Nectarosiphon) persicae (Sulzer) (7,46 %), Diuraphis noxia (Mordvilko) (5,23 %), Brachycaudus spp. (3,73 %), Sitobion avenae (F.) (2,51 %), Macrosiphum euphorbiae (Thomas) (2,46 %), Rhopalosiphum spp. (2,20 %) und Therioaphis spp. (1,99 %). Die zur Gattung Aphis gehörenden Arten waren in allen beprobten Regionen am häufigsten, obgleich M. (N.) persicae in den Regionen Zaragoza und Pamplona auch sehr häufig vorkam. D. noxia trat häufig in der Madrider Region auf. Ein erster Höhehoug punkt des Blattlausaufretens wurde in den meisten Regionen und Jahren schon bald nach dem Auspflanzen (Mai–Juni) beobachtet.This work was supported by the Interministerial Commision for Science and Technology of Spain (Comisión Interministerial de Ciencia y Tecnología, grant AGR91-0448)..Peer reviewe

The origin of the Acheulean: the 1.7 million-year-old site of FLK West, Olduvai Gorge (Tanzania)

The appearance of the Acheulean is one of the hallmarks of human evolution. It represents the emergence of a complex behavior, expressed in the recurrent manufacture of large-sized tools, with standardized forms, implying more advance forethought and planning by hominins than those required by the precedent Oldowan technology. The earliest known evidence of this technology dates back to c. 1.7 Ma. and is limited to two sites (Kokiselei [Kenya] and Konso [Ethiopia]), both of which lack fauna. The functionality of these earliest Acheulean assemblages remains unknown. Here we present the discovery of another early Acheulean site also dating to c. 1.7 Ma from Olduvai Gorge. This site provides evidence of the earliest steps in developing the Acheulean technology and is the oldest Acheulean site in which stone tools occur spatially and functionally associated with the exploitation of fauna. Simple and elaborate large-cutting tools (LCT) and handaxes co-exist at FLK West, showing that complex cognition was present from the earliest stages of the Acheulean. Here we provide a detailed technological study and evidence of the use of these tools on the butchery and consumption of fauna, probably by early Homo erectus sensu lato

Clinical and hospitalisation predictors of COVID-19 in the first month of the pandemic, Portugal

COVID-19 mainly presents as a respiratory disease with flu-like symptoms, however, recent findings suggest that non-respiratory symptoms can occur early in the infection and cluster together in different groups in different regions. We collected surveillance data among COVID-19 suspected cases tested in mainland Portugal during the first wave of the pandemic, March-April 2020. A multivariable logistic-regression analysis was performed to ascertain the effects of age, sex, prior medical condition and symptoms on the likelihood of testing positive and hospitalisation. Of 25,926 COVID-19 suspected cases included in this study, 5,298 (20%) tested positive. Symptoms were grouped into ten clusters, of which two main ones: one with cough and fever and another with the remainder. There was a higher odds of a positive test with increasing age, myalgia and headache. The odds of being hospitalised increased with age, presence of fever, dyspnoea, or having a prior medical condition although these results varied by region. Presence of cough and other respiratory symptoms did not predict COVID-19 compared to non-COVID respiratory disease patients in any region. Dyspnoea was a strong determinant of hospitalisation, as well as fever and the presence of a prior medical condition, whereas these results varied by region.The author(s) received no specific funding for this work

Magnetic field dependence and bottlenecklike behavior of the ESR spectra in YbRh2Si2

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Electron spin resonance (ESR) experiments at different fields or frequencies (4.1 <=nu <= 34.4 GHz) in the Kondo lattice (T-K similar or equal to 25 K) YbRh2Si2 single-crystal compounds confirmed the observation of a single anisotropic Dysonian resonance with g(perpendicular to c)congruent to 3.55 and no hyperfine components for 4.2 less than or similar to T less than or similar to 20 K. However, our studies differently reveal that (i) the ESR spectra for H-perpendicular to c show strong-field-dependent spin-lattice relaxation, (ii) a weak-field and temperature-dependent effective g value, (iii) a dramatic suppression of the ESR intensity beyond 15% of Lu doping, and (iv) a strong sample and Lu-doping (<= 15%) dependence of the ESR data. These results suggest a different scenario where the ESR signal may be associated to a coupled Yb3+-conduction electron resonant collective mode with a strong bottleneck and dynamiclike behavior.793Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)NSF (USA)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq

Origin and Epidemiological History of HIV-1 CRF14_BG

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Users must also make clear the license terms under which the work was published. CC BY Licence: http://creativecommons.org/licenses/by/4.0/Background: CRF14_BG isolates, originally found in Spain, are characterized by CXCR4 tropism and rapid disease progression. This study aimed to identify the origin of CRF14_BG and reconstruct its epidemiological history based on new isolates from Portugal.Methodology/Principal Findings: C2V3C3 env gene sequences were obtained from 62 samples collected in 1993–1998 from Portuguese HIV-1 patients. Full-length genomic sequences were obtained from three patients. Viral subtypes, diversity, divergence rate and positive selection were investigated by phylogenetic analysis. The molecular structure of the genomes was determined by bootscanning. A relaxed molecular clock model was used to date the origin of CRF14_BG. Geno2pheno was used to predict viral tropism. Subtype B was the most prevalent subtype (45 sequences; 73%) followed by CRF14_BG (8; 13%), G (4; 6%), F1 (2; 3%), C (2; 3%) and CRF02_AG (1; 2%). Three CRF14_BG sequences were derived from 1993 samples. Near full-length genomic sequences were strongly related to the CRF14_BG isolates from Spain. Genetic diversity of the Portuguese isolates was significantly higher than the Spanish isolates (0.044 vs 0.014, P,0.0001). The mean date of origin of the CRF14_BG cluster was estimated to be 1992 (range, 1989 and 1996) based on the subtype G genomic region and 1989 (range, 1984–1993) based on the subtype B genomic region. Most CRF14_BG strains (78.9%) were predicted to be CXCR4. Finally, up to five amino acids were under selective pressure in subtype B V3 loop whereas only one was found in the CRF14_BG cluster.Conclusions: CRF14_BG emerged in Portugal in the early 1990 s soon after the beginning of the HIV-1 epidemics, spread to Spain in late 1990 s as a consequence of IVDUs migration and then to the rest of Europe. CXCR4 tropism is a general characteristic of this CRF that may have been selected for by escape from neutralizing antibody response

International Variation in Severe Exacerbation Rates in Patients With Severe Asthma.

BACKGROUND: Exacerbation frequency strongly influences treatment choices in patients with severe asthma. RESEARCH QUESTION: What is the extent of the variability of exacerbations rate across countries and its implications in disease management? STUDY DESIGN AND METHODS: We retrieved data from the International Severe Asthma Registry, an international observational cohort of patients with a clinical diagnosis of severe asthma. We identified patients ≥ 18 years of age who did not initiate any biologics prior to baseline visit. A severe exacerbation was defined as the use of oral corticosteroids for ≥ 3 days or asthma-related hospitalization/ED visit. A series of negative binomial models were applied to estimate country-specific severe exacerbation rates during 365 days of follow-up, starting from a naïve model with country as the only variable to an adjusted model with country as a random-effect term and patient and disease characteristics as independent variables. RESULTS: The final sample included 7,510 patients from 17 countries (56% from the United States), contributing to 1,939 severe exacerbations (0.27/person-year). There was large between-country variation in observed severe exacerbation rate (minimum, 0.04 [Argentina]; maximum, 0.88 [Saudi Arabia]; interquartile range, 0.13-0.54), which remained substantial after adjusting for patient characteristics and sampling variability (interquartile range, 0.16-0.39). INTERPRETATION: Individuals with similar patient characteristics but coming from different jurisdictions have varied severe exacerbation risks, even after controlling for patient and disease characteristics. This suggests unknown patient factors or system-level variations at play. Disease management guidelines should recognize such between-country variability. Risk prediction models that are calibrated for each jurisdiction will be needed to optimize treatment strategies

Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both.

BACKGROUND: Patients with severe asthma may present with characteristics representing overlapping phenotypes, making them eligible for more than one class of biologic. Our aim was to describe the profile of adult patients with severe asthma eligible for both anti-IgE and anti-IL5/5R and to compare the effectiveness of both classes of treatment in real life. METHODS: This was a prospective cohort study that included adult patients with severe asthma from 22 countries enrolled into the International Severe Asthma registry (ISAR) who were eligible for both anti-IgE and anti-IL5/5R. The effectiveness of anti-IgE and anti-IL5/5R was compared in a 1:1 matched cohort. Exacerbation rate was the primary effectiveness endpoint. Secondary endpoints included long-term-oral corticosteroid (LTOCS) use, asthma-related emergency room (ER) attendance, and hospital admissions. RESULTS: In the matched analysis (n = 350/group), the mean annualized exacerbation rate decreased by 47.1% in the anti-IL5/5R group and 38.7% in the anti-IgE group. Patients treated with anti-IL5/5R were less likely to experience a future exacerbation (adjusted IRR 0.76; 95% CI 0.64, 0.89; p < 0.001) and experienced a greater reduction in mean LTOCS dose than those treated with anti-IgE (37.44% vs. 20.55% reduction; p = 0.023). There was some evidence to suggest that patients treated with anti-IL5/5R experienced fewer asthma-related hospitalizations (IRR 0.64; 95% CI 0.38, 1.08), but not ER visits (IRR 0.94, 95% CI 0.61, 1.43). CONCLUSIONS: In real life, both anti-IgE and anti-IL5/5R improve asthma outcomes in patients eligible for both biologic classes; however, anti-IL5/5R was superior in terms of reducing asthma exacerbations and LTOCS use

Exploring Definitions and Predictors of Severe Asthma Clinical Remission Post-Biologic in Adults.

RATIONALE: There is no consensus on criteria to include in an asthma remission definition in real-life. Factors associated with achieving remission post-biologic-initiation remain poorly understood. OBJECTIVES: To quantify the proportion of adults with severe asthma achieving multi-domain-defined remission post-biologic-initiation and identify pre-biologic characteristics associated with achieving remission which may be used to predict it. METHODS: This was a longitudinal cohort study using data from 23 countries from the International Severe Asthma Registry. Four asthma outcome domains were assessed in the 1-year pre- and post-biologic-initiation. A priori-defined remission cut-offs were: 0 exacerbations/year, no long-term oral corticosteroid (LTOCS), partly/well-controlled asthma, and percent predicted forced expiratory volume in one second ≥80%. Remission was defined using 2 (exacerbations + LTOCS), 3 (+control or +lung function) and 4 of these domains. The association between pre-biologic characteristics and post-biologic remission was assessed by multivariable analysis. MEASUREMENTS AND MAIN RESULTS: 50.2%, 33.5%, 25.8% and 20.3% of patients met criteria for 2, 3 (+control), 3 (+lung function) and 4-domain-remission, respectively. The odds of achieving 4-domain remission decreased by 15% for every additional 10-years asthma duration (odds ratio: 0.85; 95% CI: 0.73, 1.00). The odds of remission increased in those with fewer exacerbations/year, lower LTOCS daily dose, better control and better lung function pre-biologic-initiation. CONCLUSIONS: One in 5 patients achieved 4-domain remission within 1-year of biologic-initiation. Patients with less severe impairment and shorter asthma duration at initiation had a greater chance of achieving remission post-biologic, indicating that biologic treatment should not be delayed if remission is the goal. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Effectiveness of initiating biologics in severe asthma patients with high steroid exposure

Peer reviewedPostprin